Physician profile
John Michael Barnard
NPI 1639599608
$3,269.06
in general payments reported to CMS, 2019-2025
19 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $563 · 2021: $783 · 2022: $332 · 2023: $257 · 2024: $604 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $795.15 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $525.18 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $394.39 | 2019-2024 | Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.68 | 2020-2025 | Lifevest |
| Abbvie INC. | $241.58 | 2021-2025 | Teflaro |
| Merck Sharp & Dohme LLC | $189.74 | 2022-2024 | Verquvo, Dificid |
| Amgen INC. | $159.14 | 2019-2020 | |
| Inari Medical, INC. | $133.50 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $109.36 | 2019-2024 | |
| Abiomed | $106.59 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $105.22 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $84.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.93 | 2021-2023 | Stiolto Respimat, Jardiance, Spiriva Respimat |
| Stryker Corporation | $30.48 | 2025 | Artix Mt |
| Alexion Pharmaceuticals, INC. | $24.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $20.29 | 2023 | Hillrom - Life 2000 Ventilation System |
| Glaxosmithkline, LLC. | $19.90 | 2020 | |
| Mallinckrodt Hospital Products INC. | $15.21 | 2024 | Terlivaz |
| Allergan, INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.